Tampa General Hospital Ranked One of America’s Top Specialized Hospitals for Cancer, Cardiac and Orthopaedic Care

Tampa General Hospital's Cancer Institute, Heart & Vascular Institute and Orthopaedic Institute received national recognition for excellent quality of care, patient outcomes and care experience from Newsweek after recently ranking among U.S. News & World Report's 2024-2025 Best Hospitals.

Tampa General Hospital (TGH) is ranked as one of America’s Best Specialized Hospitals for 2024, according to Newsweek and Statista. The magazine’s list ranked the nation’s 200 leading cancer hospitals, 175 leading cardiac hospitals and 175 leading orthopedic hospitals in the U.S., with the TGH Cancer Institute listed among the top 10 cancer hospitals in Florida for the second consecutive year.

For the first time, Tampa General Hospital’s Heart & Vascular Institute and Orthopaedic Institute are each ranked among the top five cardiac and orthopedic hospitals in Florida, respectively, making Tampa General the only hospital in the Tampa Bay region to be ranked on all three lists.

“At Tampa General, we are proud to say that we don’t just practice medicine – we define it,” said John Couris, president and CEO of Tampa General Hospital. “As the region’s only academic-based health system, our continued recognition and exceptional rankings in multiple specialties and from leading national news sources, such as Newsweek, reinforces that our team across the enterprise is truly setting the standard for the delivery of world-class specialty and academic-based care.”

The TGH Cancer Institute continues to revolutionize cancer treatment as one of the state’s few cancer centers powered by university-affiliated academic medicine in partnership with the USF Health Morsani College of Medicine. Staffed by some of the world’s most renowned medical, radiation, and surgical oncologists and researchers, the TGH Cancer Institute offers unmatched access to state-of-the-art diagnostic tools and therapies.

The Institute is also accredited by the Commission on Cancer (CoC), a quality program established by the American College of Surgeons (ACS) in recognition of meeting 34 quality care standards, taking a multidisciplinary approach to delivering high-quality, patient-centered cancer care and demonstrating a commitment to improving patient outcomes and quality of life for all cancer patients.

“Cancer treatment is a journey unique to each individual, requiring not only specialized expertise, but also deep empathy and understanding,” said Dr. Eduardo M. Sotomayor, director of Tampa General’s Cancer Institute. “It’s an honor to be recognized nationally not only for how we go above and beyond to extend and enhance the lives of our patients, but to grow and strengthen our Institute, and in turn, define the future of cancer care and therapy discovery for our region.”

“We believe exceptional cancer care goes hand-in-hand with groundbreaking research,” said Dr. Abraham Schwarzberg, executive vice president, chief of oncology and president of the Tampa General Provider Network (TGPN), and vice president of clinical and translational research. “This latest recognition is a testament to our collective team’s dedication to pushing the boundaries of what innovation looks like in oncology.”

Tampa General’s 200-bed Heart & Vascular Institute is staffed by 86 dedicated and highly experienced specialists across seven centers of excellence and houses 15 subspecialties, all collaborating to provide the highest possible level of patient care.

The TGH Heart & Vascular Institute leverages multidisciplinary collaboration to provide the highest level of patient care through its seven centers of excellence and programs, including:

  • A comprehensive, hybrid, complex coronary program – a partnership between cardiac surgery and interventional cardiology – where partner physicians meet together with patients and collaborate on the best treatment approach for each patient.
  • A dedicated limb preservation and complex peripheral arterial disease (PAD) program, which is the first and only of its kind in the Tampa Bay region offers a true multidisciplinary, integrated and evidence-based approach to prevent amputations and improve quality of life for patients managing complex PAD.
  • One of the most robust heart transplant programs in Florida and one of the busiest programs in the nation, which is home to the state’s first and only cardiogenic shock program with extracorporeal membrane oxygenation (ECMO) cannulation in the catheterization laboratory and is a recognized leader in mechanical circulatory support therapy.
  • A women’s heart program which is devoted exclusively to meeting the unique needs of women through high-quality, evidence-based care and is staffed by highly specialized, academic and multidisciplinary cardiac specialists who are experts in identifying, preventing and treating heart conditions in female patients throughout their lifespans.

“We know patients and their loved ones count on these rankings to make the best and most-informed decisions about which hospitals and providers to entrust with their health, and we don’t take that lightly,” said Dr. Murray Shames, interim co-chief of the TGH Heart & Vascular Institute and professor and chair of the Department of Surgery at the USF Health Morsani College of Medicine. “We are proud to deliver truly award-winning care that makes a difference for our community and every patient we serve.”

“Because our Institute is part of the region’s only university-affiliated academic health system, we are uniquely positioned to address our community’s most complex health needs with unmatched clinical expertise and breakthrough research,” said Dr. Benjamin Mackie, interim vice president and co-chief of TGH Heart & Vascular Institute, medical director of HVI Heart Failure Center of Excellence and medical director of Heart Transplantation.

The TGH Orthopaedic Institute, which received notable recognition from Newsweek and Statista for its hip replacement surgery outcomes and is the region’s leading provider of orthopaedic care, uses advanced technology and treatment options to provide high-quality care and positive outcomes for even the most complex orthopaedic conditions, including hip and knee arthritis, bone fractures, spinal deformities, musculoskeletal tumors, joint infection and shoulder, foot and hand disorders. Four centers of excellence make up the Institute, which also offers comprehensive programs for hip and knee replacements, shoulder, ankle and elbow conditions

Staffed by highly specialized, board-certified and fellowship-trained physicians, the Institute offers innovative, minimally invasive options for joint replacement procedures by harnessing robot-assisted technology and 3D printing, enabling greater surgical precision and reducing post-surgical pain and patient recovery time. As Tampa Bay’s only Level I Trauma Center, Tampa General also offers emergency orthopaedic care and reconstructive surgery for traumatic injuries.

“Our ranking as one of the top orthopaedic institutes in the nation demonstrates our relentless pursuit of excellence, both in the quality of care we deliver and in setting a new standard for innovation in orthopaedic surgery,” said Dr. Roy Sanders, chief of the TGH Orthopaedic Institute, professor and chair in the Department of Orthopaedic Surgery at the USF Health Morsani College of Medicine and president of the Florida Orthopaedic Institute. “Our exceptional team of providers and caregivers represent the very best of what academic medicine offers patients in our community and beyond.”

Newsweek and Statista selected the list of America’s top cancer, cardiac and orthopaedic hospitals based on the following data sources:

  • A Nationwide Online Survey: Health care professionals and hospital managers with knowledge about the respective medical field were asked to recommend the leading specialized hospitals in the U.S.

  • Hospital Quality Metrics: Hospital quality metrics with a focus on indicators and accreditations relevant to oncology, cardiac care and orthopaedic care were considered.

  • Results from Patient Surveys: Publicly available data from hospital patient surveys were also used to analyze the patient experience.

The recognition Tampa General earned from Newsweek is the latest in a series of awards, recognitions and milestones celebrated, including:

  • Becker’s Hospital Review Great Hospitals in America – August 2024

  • U.S. News & World Report 2024-2025 Best Hospitals #1 hospital in Tampa Bay, #2 hospital in Florida and among the nation’s top 50 hospitals in eight medical specialties – July 2024

  • Becker’s Hospital Review 100 Hospitals and Health Systems with Great Heart Programs – July 2024

  • Newsweek Best Maternity Hospitals – May 2024

  • Forbes Magazine America’s Best Large Employers – March 2024

  • Newsweek World’s Best Hospitals – March 2024

  • U.S. News & World Report Nation’s Best in Maternity Care – January 2024

  • Becker’s Hospital Review Top 20 Largest Hospitals in the Nation – January 2024

  • Fourth in the Nation for Transplants by Volume – January 2024

  • Newsweek #2 Best-in-State Hospital – October 2023

  • Becker’s Hospital Review 100 Hospitals and Health Systems with Great Orthopedic Programs – October 2023

  • Becker’s Hospital Review 100 Hospitals and Health Systems with Great Oncology Programs – November 2023

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”